South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika
- Written by PR Newswire
![]() |
- SK bioscience completed the acquisition of German CDMO company IDT Biologika with over a century of history that enables immediate expansion in revenue and infrastructure.
- The company aims to double sales of IDT Biologika by 2028 through new business projects and operational efficiency.
- The company will invest in high-growth businesses such as stage...
Read more: South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika















